Article Details

BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission - Newswire.CA

Retrieved on: 2021-09-28 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

BioVaxys Begins Toxicity Study Ahead of CoviDTH IND Submission - Newswire.CA. View article details on hiswai:

Excerpt

VANCOUVER, BC, Sept. 28, 2021 /CNW/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or "Company"), announced today that it ...

Article found on: www.newswire.ca

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up